Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |